Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MIST

Milestone Pharmaceuticals Inc.

Healthcare · USD

Set alert

Price alert · MIST

All alert types
0.73 USD -0.06 -7.55%
As of Oct 30, 2026 Extended hours 0.74 +0.99%
Bid
0.73 × 1
Ask
0.74 × 1
0.7259 Day range 0.7997
0.644 52-week range 2.95
YTD
-63.86%
1 year
-61.17%
Open
0.79
Prev close
0.7896
Mkt cap
90.88M
Vol
730.16K
Avg vol
1.35M
EPS
-0.68
P/E
0.00
Div yield
0.00%
More statistics
Low
0.7259
High
0.7997
Forward P/E
-2.15
Beta
1.73
Short ratio
2.46
Inst. own
57.01%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.71
200-d avg
1.58
1y target
10.25

5D chart

Chart tools
Interval
1m5m15m30m
MIST five-day price chart0.630.680.730.780.84Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-3.68 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.7×
FY 2017: -45.2×FY 2018: -15.7×FY 2019: -4.6×FY 2020: -3.9×FY 2021: -6.4×FY 2022: -2.9×FY 2023: -1.2×FY 2024: -3.5×FY 2025: -2.7×
FY 2017 5y median -2.9× FY 2025
P/S 110×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 18.3×FY 2022: 33.6×FY 2023: 71.7×FY 2024: 0.0×FY 2025: 110×
FY 2017 5y median 33.6× FY 2025
P/B 4.1×
FY 2017: -11.0×FY 2018: -6.6×FY 2019: 2.2×FY 2020: 1.4×FY 2021: 2.4×FY 2022: 2.5×FY 2023: 4.3×FY 2024: 11.2×FY 2025: 4.1×
FY 2017 5y median 4.1× FY 2025
P/FCF -3.4×
FY 2017: -44.9×FY 2018: -17.3×FY 2019: -4.9×FY 2020: -3.9×FY 2021: -8.2×FY 2022: -3.2×FY 2023: -1.5×FY 2024: -5.1×FY 2025: -3.4×
FY 2017 5y median -3.4× FY 2025
EV/EBITDA -2.6×
FY 2017: -42.7×FY 2018: -11.9×FY 2019: -2.3×FY 2020: -2.5×FY 2021: -3.8×FY 2022: -2.8×FY 2023: -1.9×FY 2024: -4.7×FY 2025: -2.6×
FY 2017 5y median -2.8× FY 2025
EV/Sales 100×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 10.7×FY 2022: 32.6×FY 2023: 110×FY 2024: 0.0×FY 2025: 100×
FY 2017 5y median 32.6× FY 2025
FCF Yield -29.1%
FY 2017: -2.2%FY 2018: -5.8%FY 2019: -20.4%FY 2020: -25.8%FY 2021: -12.1%FY 2022: -31.4%FY 2023: -64.9%FY 2024: -19.7%FY 2025: -29.1%
FY 2017 5y median -29.1% FY 2025

Profitability

Gross Margin 92.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 92.6%
FY 2017 5y median 100.0% FY 2025
Operating Margin -4041.7%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -287.2%FY 2022: -1192.8%FY 2023: -6109.8%FY 2024: 0.0%FY 2025: -4041.7%
FY 2017 5y median -1192.8% FY 2025
Net Margin -4078.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -285.7%FY 2022: -1167.8%FY 2023: -5968.5%FY 2024: 0.0%FY 2025: -4078.8%
FY 2017 5y median -1167.8% FY 2025
ROE -151.0%
FY 2017: 24.4%FY 2018: 42.0%FY 2019: -48.1%FY 2020: -34.9%FY 2021: -38.1%FY 2022: -88.0%FY 2023: -355.9%FY 2024: -315.8%FY 2025: -151.0%
FY 2017 5y median -151.0% FY 2025
ROIC -62.0%
FY 2017: -31.8%FY 2018: -28.5%FY 2019: -50.1%FY 2020: -35.2%FY 2021: -38.0%FY 2022: -86.6%FY 2023: -89.1%FY 2024: -62.0%FY 2025: -62.0%
FY 2017 5y median -62.0% FY 2025
ROA -55.5%
FY 2017: -29.3%FY 2018: -26.3%FY 2019: -44.7%FY 2020: -33.3%FY 2021: -35.8%FY 2022: -78.4%FY 2023: -79.3%FY 2024: -55.0%FY 2025: -55.5%
FY 2017 5y median -55.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -66.7%FY 2023: -80.0%FY 2024: -100.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -48.4%
FY 2017: 0.0%FY 2018: -188.1%FY 2019: -143.0%FY 2020: 12.4%FY 2021: 15.1%FY 2022: -38.5%FY 2023: -2.4%FY 2024: 31.1%FY 2025: -48.4%
FY 2017 FY 2025
EPS (diluted) -11.9%
FY 2017: 0.0%FY 2018: -188.2%FY 2019: -257.1%FY 2020: 51.4%FY 2021: 40.0%FY 2022: -32.4%FY 2023: -3.0%FY 2024: 51.8%FY 2025: -11.9%
FY 2017 FY 2025
Free Cash Flow -70.8%
FY 2017: 0.0%FY 2018: -160.3%FY 2019: -145.0%FY 2020: 1.6%FY 2021: 34.5%FY 2022: -58.7%FY 2023: 11.8%FY 2024: 37.9%FY 2025: -70.8%
FY 2017 FY 2025

Financial Health

Current Ratio 8.0×
FY 2017: 17.2×FY 2018: 19.4×FY 2019: 14.7×FY 2020: 24.1×FY 2021: 17.6×FY 2022: 11.7×FY 2023: 10.1×FY 2024: 9.1×FY 2025: 8.0×
FY 2017 5y median 10.1× FY 2025
Quick Ratio 8.0×
FY 2017: 17.2×FY 2018: 19.4×FY 2019: 14.7×FY 2020: 24.1×FY 2021: 17.6×FY 2022: 11.7×FY 2023: 10.1×FY 2024: 9.1×FY 2025: 8.0×
FY 2017 5y median 10.1× FY 2025
Debt / Equity 1.4×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 3.1×FY 2024: 4.2×FY 2025: 1.4×
FY 2017 5y median 1.4× FY 2025
Net Debt / EBITDA 0.2×
FY 2017: 1.3×FY 2018: 3.7×FY 2019: 2.1×FY 2020: 1.4×FY 2021: 2.7×FY 2022: 0.1×FY 2023: -0.7×FY 2024: -0.8×FY 2025: 0.2×
FY 2017 5y median 0.1× FY 2025
Interest Coverage -16.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -22.3×FY 2020: -69.8×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -23.9×FY 2024: 11.8×FY 2025: -16.3×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31